Tahoe Resources Acquires 2% NSR Royalty at Bell Creek, Signs Letter of Intent to Obtain 100% Interest in Whitney Joint Venture
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake